Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
March 28, 2022 - Novo Nordisk announced the FDA approval of a 2 mg dose of Ozempic (semaglutide).
Return to publications